10-QPeriod: Q3 FY2023

AXON ENTERPRISE, INC. Quarterly Report for Q3 Ended Sep 30, 2023

Filed November 7, 2023For Securities:AXON

Summary

Axon Enterprise, Inc. (AXON) reported strong revenue growth in the third quarter and first nine months of 2023, driven by increases in both its TASER and Software and Sensors segments. Net sales for the quarter reached $413.6 million, a 32.7% increase year-over-year, while the nine-month total reached $1.1 billion, up 32.5%. This growth was fueled by robust demand for Axon Evidence and cloud services, Axon Body Cameras, and Axon Fleet Systems, alongside steady performance in TASER devices and cartridges. The company demonstrated improved operational efficiency, with income from operations rising significantly to $55.1 million for the quarter and $112.0 million for the nine months, compared to the prior year periods. While gross margin percentage saw a slight dip due to the ramp-up of new products like TASER 10 and increased costs in certain hardware and professional services, the overall dollar increase in gross margin was substantial. The company also managed its operating expenses effectively, with SG&A and R&D expenses growing at a slower pace than revenue, indicating good cost control as the company scales.

Financial Highlights

52 data points
Beta

Revenue

$413.28M

62.1% Gross Margin

Net Income

$61.31M

14.8% Net Margin

EPS (Diluted)

$0.81

Total Assets

$3.25B

Cash & Equivalents

$408.01M

Free Cash Flow

$48.92M

Financial Statements
Beta
Revenue$413.28M
Cost of Revenue$156.62M
Gross Profit$256.66M
R&D Expenses$76.88M
SG&A Expenses$122.36M
Operating Expenses$199.24M
Operating Income$57.42M
Net Income$61.31M
EPS (Basic)$0.82
EPS (Diluted)$0.81
Shares Outstanding (Basic)74.83M
Shares Outstanding (Diluted)75.95M

Key Highlights

  • 1Revenue increased by 32.7% to $413.6 million in Q3 2023 and by 32.5% to $1.1 billion in the first nine months of 2023, compared to the prior year periods.
  • 2Income from operations significantly improved, reaching $55.1 million in Q3 2023 and $112.0 million for the nine months, up from $32.1 million and $70.7 million, respectively.
  • 3The Software and Sensors segment continued its strong growth trajectory, with net sales increasing by 50.4% in Q3 and 48.2% for the nine months.
  • 4Axon Evidence and cloud services revenue saw substantial increases, growing 55.5% in Q3 and 55.0% for the nine months, reflecting continued adoption of their cloud solutions.
  • 5Despite a slight decrease in gross margin percentage (61.7% in Q3 2023 vs. 62.0% in Q3 2022), gross margin dollars increased significantly due to higher sales volumes.
  • 6The company maintained a strong liquidity position with $406.0 million in cash and cash equivalents as of September 30, 2023.
  • 7A material weakness in internal control over financial reporting related to revenue recognition and deferred revenue was identified and is being remediated; however, the cumulative impact on past financial statements was immaterial.

Frequently Asked Questions

Revenue growth was primarily driven by strong performance in the Software and Sensors segment, particularly the Axon Evidence and cloud services, Axon Body Cameras and Accessories, and Axon Fleet Systems. The TASER segment also contributed positively with increases in TASER Devices (Professional) and Cartridges, partly due to the ramp-up of the new TASER 10 product.

Profitability saw a significant improvement. Income from operations increased substantially year-over-year for both the third quarter and the first nine months. While the gross margin percentage experienced a slight decrease, this was offset by higher sales volumes, leading to an increase in gross margin dollars. Operating expenses were managed effectively relative to revenue growth.

Axon maintains a strong liquidity position. As of September 30, 2023, the company had $406.0 million in cash and cash equivalents, and a total of $1.1 billion in cash, cash equivalents, and available-for-sale investments. The company also has an undrawn $200 million revolving credit facility, further bolstering its financial flexibility.

Key risks include the substantial dependence on law enforcement markets and the acceptance of their products, potential declines in gross margins due to product mix shifts, risks associated with supply chain disruptions and component availability, and potential impacts from litigation and regulatory changes. The company also disclosed a material weakness in internal control over financial reporting related to revenue recognition, which is currently under remediation.